Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease

Journal of Thrombosis and Thrombolysis

Volumn 26, Issue 3, 2008, Pages 211-217

  Onalan, Orhan ^a,b   Balta, Gunay ^a   Oto, Ali ^a   Kabakci, Giray ^a   Tokgozoglu, Lale ^a   Aytemir, Kudret ^a   Altay, Cigdem ^a   Gurgey, Aytemiz ^a   Nazli, Nasih ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Genetic polymorphism; Myocardial infarction; Plasminogen activator inhibitor 1

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE DELETION; GENE FREQUENCY; GENE FUNCTION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 56349095296     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0083-z     Document Type: Article

References (44)

1. Agirbasli M (2005) Pivotal role of plasminogen-activator inhibitor 1 in vascular disease. Int J Clin Pract 59:102-106
2. Kohler HP, Grant PJ (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342:1792-1801
3. Hamsten A, de Faire U, Walldius G et al (1987) Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 2:3-9
4. Cortellaro M, Cofrancesco E, Boschetti C et al (1993) Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT group. Arterioscler Thromb 13:1412-1417
5. Hamsten A, Wiman B, de Faire U, Blomback M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557-1563
6. Collet JP, Montalescot G, Vicaut E et al (2003) Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality. Circulation 108:391-394
7. Deng G, Curriden SA, Hu G, Czekay RP, Loskutoff DJ (2001) Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin. J Cell Physiol 189:23-33
8. Sobel BE (1999) Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox. Circulation 99:2496-2498
9. Schneider DJ, Hayes M, Wadsworth M et al (2004) Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1). J Histochem Cytochem 52:1091-1099
10. Libby P, Theroux P (2005) Pathophysiology of coronary artery disease. Circulation 111:3481-3488
11. Ny T, Sawdey M, Lawrence D, Millan JL, Loskutoff DJ (1986) Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor. Proc Natl Acad Sci USA 83:6776-6780
12. Eriksson P, Kallin B, van't Hooft FM, Bavenholm P, Hamsten A (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 92:1851-1855
13. Dawson S, Hamsten A, Wiman B, Henney A, Humphries S (1991) Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 11:183-190
14. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268:10739-10745
15. Ye S, Green FR, Scarabin PY et al (1995) The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde. Thromb Haemost 74:837-841
16. Anvari A, Schuster E, Gottsauner-Wolf M, Wojta J, Huber K (2001) PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease. Thromb Res 103:103-107
17. Hoekstra T, Geleijnse JM, Schouten EG, Kluft C (2002) Diurnal variation in PAI-1 activity predominantly confined to the 4G-allele of the PAI-1 gene. Thromb Haemost 88:794-798
18. van der Bom JG, Bots ML, Haverkate F, Kluft C, Grobbee DE (2003) The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1. Blood 101:1841-1844
19. Ossei-Gerning N, Mansfield MW, Stickland MH, Wilson IJ, Grant PJ (1997) Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. Arterioscler Thromb Vasc Biol 17:33-37
20. Iacoviello L, Burzotta F, Di Castelnuovo A, Zito F, Marchioli R, Donati MB (1998) The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: A meta-analysis. Thromb Haemost 80:1029-1030
21. Iwai N, Shimoike H, Nakamura Y, Tamaki S, Kinoshita M (1998) The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes. Atherosclerosis 136:109-114
22. Mikkelsson J, Perola M, Wartiovaara U et al (2000) Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly. Thromb Haemost 84:78-82
23. Boekholdt SM, Bijsterveld NR, Moons AH, Levi M, Buller HR, Peters RJ (2001) Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: A systematic review. Circulation 104:3063-3068
24. Hindorff LA, Schwartz SM, Siscovick DS, Psaty BM, Longstreth WT Jr, Reiner AP (2002) The association of PAI-1 promoter 4G/5G insertion/ deletion polymorphism with myocardial infarction and stroke in young women. J Cardiovasc Risk 9:131-137
25. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP (1997) Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 95:59-62
26. Anderson JL, Muhlestein JB, Habashi J et al (1999) Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction. J Am Coll Cardiol 34:1778-1783
27. Gardemann A, Lohre J, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W (1999) The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease. Thromb Haemost 82:1121-1126
28. Doggen CJ, Bertina RM, Cats VM, Reitsma PH, Rosendaal FR (1999) The 4G/ 5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 82:115-120
29. Ardissino D, Mannucci PM, Merlini PA et al (1999) Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 94:46-51
30. Hooper WC, Lally C, Austin H et al (2000) The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res 99:223-230
31. Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36:959-969
32. Nordt TK, Lohrmann J, Bode C (2001) Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesis. Thromb Res 103(Suppl 1):S1-S5
33. Zhu Y, Carmeliet P, Fay WP (1999) Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 99:3050-3055
34. Stefansson S, Lawrence DA (1996) The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature 383:441-443
35. Carmeliet P, Moons L, Lijnen R et al (1997) Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: A gene targeting and gene transfer study in mice. Circulation 96:3180-3191
36. Redmond EM, Cullen JP, Cahill PA et al (2001) Endothelial cells inhibit flow-induced smooth muscle cell migration: Role of plasminogen activator inhibitor-1. Circulation 103:597-603
37. Cullen JP, Nicholl SM, Sayeed S et al (2004) Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration. Thromb Res 114:57-65
38. Hasenstab D, Lea H, Clowes AW (2000) Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening. Arterioscler Thromb Vasc Biol 20:853-859
39. de Waard V, Arkenbout EK, Carmeliet P, Lindner V, Pannekoek H (2002) Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model. Arterioscler Thromb Vasc Biol 22:1978-1983
40. Luttun A, Lupu F, Storkebaum E et al (2002) Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 22:499-505
41. Shindo J, Ishibashi T, Kijima M et al (2001) Increased plasminogen activator inhibitor-1 and apolipoprotein (a) in coronary atherectomy specimens in acute coronary syndromes. Coron Artery Dis 12:573-579
42. Ye Z, Liu EH, Higgins JP et al (2006) Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls. Lancet 367:651-658
43. Canavy I, Henry M, Morange PE et al (2000) Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost 83:212-216
44. Betriu A, Pare JC, Sanz GA et al (1981) Myocardial infarction with normal coronary arteries: A prospective clinical-angiographic study. Am J Cardiol 48:28-32